X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/06/18/2900851/35575/en/Aptose-Announces-Results-from-Annual-and-Special-Meeting-of-Shareholders.html
https://www.globenewswire.com/news-release/2024/06/14/2898921/35575/en/Aptose-Presents-Tuspetinib-TUS-Clinical-and-Preclinical-Findings-at-European-Hematology-Association-EHA-2024-Hybrid-Congress.html
https://www.globenewswire.com/news-release/2024/06/03/2892626/35575/en/Aptose-Announces-Closing-of-4-43-Million-Registered-Direct-Offering-Priced-At-the-Market-Under-Nasdaq-Rules.html
https://www.globenewswire.com/news-release/2024/05/31/2891487/35575/en/Aptose-Announces-4-43-Million-Registered-Direct-Offering-Priced-At-the-Market-Under-Nasdaq-Rules.html
https://www.globenewswire.com/news-release/2024/05/14/2881837/35575/en/Aptose-Reports-Results-for-the-First-Quarter-2024.html
https://www.globenewswire.com/news-release/2024/05/06/2876190/35575/en/Aptose-to-Report-First-Quarter-2024-Financial-Results-and-Provide-Clinical-Strategy-Update-on-Tuesday-May-14-2024.html
https://www.globenewswire.com/news-release/2024/03/26/2852721/35575/en/Aptose-Reports-Results-for-the-Fourth-Quarter-and-Full-Year-2023.html
https://www.globenewswire.com/news-release/2024/03/18/2848185/35575/en/Aptose-to-Report-Fourth-Quarter-and-Year-End-2023-Financial-Results-and-Provide-Corporate-Update-on-Tuesday-March-26-2024.html
https://www.globenewswire.com/news-release/2024/03/18/2848185/35575/en/Aptose-to-Report-Fourth-Quarter-and-Year-End-2023-Financial-Results-and-Provide-Corporate-Update-on-Tuesday-March-26-2024.html
https://www.globenewswire.com/news-release/2024/01/31/2821542/35575/en/Aptose-Announces-Closing-of-9-7-Million-Public-Offering-and-Concurrent-4-Million-Private-Placement-with-Hanmi-Pharmaceutical-Including-Full-Exercise-of-Over-Allotment-Option.html
Market Place
Share 
